Position in RDY
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$1,084,357
-$14,875 QoQ
Shares Held
78,293
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Derivatives in RDY
reported options exposure · as of Dec 31, 2024CallValue
$339,485
CallShares
21,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026HSBC HOLDINGS PLC holds $402,322,473 across 27 Drug Manufacturers - Specialty & Generic names. RDY ranks #8 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,063,170 | $243,887,321 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
119,235 | $70,703,969 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
961,140 | $28,949,535 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
184,222 | $24,269,403 | |
| 5 | VTRS |
Viatris Inc
|
1,715,900 | $23,181,805 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
84,159 | $1,747,140 | |
| 7 | ALKS |
Alkermes plc.
|
48,337 | $1,709,196 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
This page
|
78,293 | $1,084,357 |
All Filings in RDY
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,084,357 | 78,293 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $1,099,232 | 78,293 | Shares | Sole | 2026-03-20 | |
| 2025-09-30 | $2,648,426 | 189,444 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,376,146 | 91,560 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,207,676 | 91,560 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $339,485 | 21,500 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $1,445,732 | 91,560 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $278,075 | 3,500 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $2,971,986 | 37,407 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,850,039 | 37,407 | Shares | Sole | 2024-08-12 | |
| 2024-06-30 | $304,760 | 4,000 | Call | Sole | 2024-08-12 | |
| 2024-03-31 | $293,400 | 4,000 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $2,768,375 | 37,742 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,250,356 | 32,342 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,162,709 | 32,342 | Shares | Sole | 2023-11-13 | |
| 2023-09-30 | $501,525 | 7,500 | Call | Sole | 2023-11-13 | |
| 2023-06-30 | $3,138,523 | 49,731 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,643,316 | 46,431 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,871,659 | 55,491 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,300,491 | 24,847 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,315,346 | 23,747 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,323,420 | 23,747 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,555,776 | 23,785 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,563,294 | 23,999 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,925,888 | 26,199 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,868,650 | 30,439 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,052,525 | 14,764 | Shares | Defined | 2021-02-25 | |
| 2020-09-30 | $1,190,449 | 17,114 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $752,954 | 14,204 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $602,570 | 14,941 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||